• 1
    Slavin RG. Nasal polyps and Sinusitis. In: MiddletonEJr, ReedChE, EllisEF, AdkinsonNFJr, YungingerJW, BusseWW, editors. Allergy principles & practice, vol. 2. St Louis, MO: Mosby, 1998: 1024.
  • 2
    Elovic A, Wong DT, Weller PF, Matossian K, Galli SJ. Expression of transforming growth factors-alpha and beta 1 messenger RNA and product by eosinophils in nasal polyps. J Allergy Clin Immunol 1994;93: 864869.
  • 3
    Ohno I, Lea RG, Flanders KC, Clark DA, Banwatt D, Dolovich J et al. Eosinophils in chronically inflamed human upper airway tissues express transforming growth factor beta 1 gene (TGF beta 1). J Clin Invest 1992;89: 16621668.
  • 4
    Mullol J, Xaubet A, Gaya A, Roca-Ferrer J, Lopez E, Fernandez JC et al. Cytokine gene expression and release from epithelial cell. A comparison study between healthy nasal mucosa and nasal polyps. Clin Exp Allergy 1995;25: 607615.
  • 5
    Walsh GM. Eosinophil granule proteins and their role in disease. Curr Opin Hematol 2001;8: 2833.
  • 6
    Teran LM, Montefort S, Douglas J, Holgate ST, Neutrophil and eosinophil chemotaxins in asthma. Q J Med 1993;86: 761769.
  • 7
    Teran LM, CCL chemokines and asthma. Immunol Today 2000;21: 235245.
  • 8
    Bachert C, Gevaert P, Holtappels G, Cuvelier C, van Cauwenberg P. Nasal polypsis: from cytokines to growth. Am J Rhinol 2000;14: 279290.
  • 9
    Bartels J, Maune S, Meyer JE, Kulke R, Schluter C, Rowert J et al. Increased eotaxin-mRNA in non-atopic and atopic nasal polyps: comparison to RANTES and MCP-3 expression. Rhinology 1997;35: 171174.
  • 10
    Jahnsen FL, Haye R, Gran E, Brandtzaeg P, Johansen FE. Glucocorticosteroids inhibit mRNA expression for eotaxin, eotaxin-2, and monocyte-chemotactic protein-4 in human airway inflammation with eosinophilia. J Immunol 1999;163: 15451551.
  • 11
    Patel VP, Kreider BL, Li Y, Li H, Leung K, Salcedo T et al. Molecular and functional characterization of two novel human C–C chemokines as inhibitors of two distinct classes of myeloid progenitors. J Exp Med 1997;185: 11631172.
  • 12
    White JR, Imburgia C, Dul E, Appelbaum, E, O'donnell K, O'shannessy DJ et al. Cloning and functional characterization of a novel human CC chemokines that blind to the CCR3 receptor and activates human eosinophils. J Leukoc Biol 1997;62: 667675.
  • 13
    Ying S, Meng O, Zeibecoglou K, Robinson, DS, Macfarlane A, Humbert M et al. Chemokines in allergen-induced late-phase cutaneous responses in atopic subjects: association of eotaxin with early 6-hour eosinophils, and of eotaxin-2 and monocyte chemoattractant protein-4 with the later 24-hour tissue eosinophilia, and relationship to basophils and other C–C chemokines (monocyte chemoattractant protein-3 and RANTES). J Immunol 1999;163: 39763984.
  • 14
    Ying S, Robinson, DS, Meng Q, Barata LT, Mceuen AR, Buckley MG et al. Eosinophil chemotactic chemokines eotaxin, eotaxin-2, RANTES, monocyte chemoattractant protein-3 (MCP-3), MCP-4, and C–C chemokine receptor 3 expression in bronchial biopsies from atopic and non-atopic (intrinsic asthmatics). J Immunol 1999;163: 63216329.
  • 15
    Brombacher F. The role of interleukin-13 in infectious diseases and allergy. Biossays 2000;22: 646656.
  • 16
    Ryan JJ. Interleukin-4 and its receptor: essential mediators of the allergic response. J Allergy Clin Immunol 1997;99: 15.
  • 17
    Mosmann TR, Sad S. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today 1996;17: 138146.
  • 18
    Zimmerman N, Hogan SP, Mishra A, Brandt EB, Bodette TR, Pope SM et al. Murine eotaxin-2: a constitutive eosinophil chemokine induced by allergen challenge and IL-4 overexpression. J Immunol 2000;165: 58395846.
  • 19
    Teran LM, Park HS, Djukanovic R, Roberts K, Holgate ST. Cultured nasal polyps from nonatopic and atopic patients release RANTES spontaneously and after stimulation with phytohemagglutinin. J Allergy Clin Immunol 1997;100: 499504.
  • 20
    Teran LM, Mochizuki M, Bartels J, Valencia, FL, Nakajima T, Hirai K et al. Th1- and Th2-type cytokines regulate the expression and production of eotaxin and RANTES by human lung fibroblasts. Am J Respir Cell Mol Biol 1999;20: 777786.
  • 21
    Teran LM, Carroll MP, Frew AJ, Redington, AE, Davies DE, Lindley I et al. Leukocyte recruitment after local endobronchial allergen challenge in asthma. Relationship to procedure and to airway interleukin-8 release. Am J Respir Crit Care Med 1996;154 (2 Pt 1):469476.
  • 22
    Zhu Z, Homer RJ, Wang Z, Chen Q, Geba GP, Wang J et al. Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. J Clin Invest 1999;103: 779788.
  • 23
    Li L, Xia Y, Nguyen A, Feng, L, Lo D. Effects of Th2 cytokines on chemokine expression in the lung; IL-13 potently induces eotaxin expression by airway epithelial cells. J Immunol 1999;162: 24772487.
  • 24
    Hamilos DL, Leung DY, Wood R, Cunningham, I, Bean DK, Yasruel Z et al. Evidence for distinct cytokine expression in allergic versus nonallergic chronic sinusitis. J Allergy Clin Immunol 1995;96: 537544.
  • 25
    Lee CH, Rhee CS, Min YG. Cytokine gene expression in nasal polyps. Ann Otol Rhinol Laryngol 1998;107: 665670.
  • 26
    Hamilos DL, Thawley SE, Kramper MA, Kamil A, Hamid QA. Effect of intranasal flucticasone on cellular infiltration, endothelial adhesion molecule expression, and proinflammatory cytokine mRNA in nasal polyp disease. J Allergy Clin Immunol 1999;103 (1 Pt 1):7987.
  • 27
    Miller CH, Pudiak DR, Hatem F, Looney RJ. Accumulation of interferon gamma-producing Th1 helper T cells in nasal polyps. Otolaryngol Head Neck Surg 1994;111: 5158.
  • 28
    Watanabe K, Jose PJ, Rankin S. Eotaxin-2 generation is differentially regulated by lypopolysaccharide and IL-4 in monocytes and macrophages. J Immunol 2002;168: 19111918.
  • 29
    Philip G, Togias AG. Nonallergic rhinitis: pathophysiology and models of study. Eur Arch Othorhinolaryngol Suppl 1995;1: 2732.